featured
Trastuzumab Plus Capecitabine vs Lapatinib Plus Capecitabine in HER2+ Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxanes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Phase II Trial of Trastuzumab Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxanes: WJOG6110B/ELTOP
Breast 2018 Aug 01;40(xx)67-75, T Takano, J Tsurutani, M Takahashi, T Yamanaka, K Sakai, Y Ito, J Fukuoka, H Kimura, H Kawabata, K Tamura, K Matsumoto, K Aogi, K Sato, K Nishio, K Nakagawa, T SaekiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.